Professional Experience 

Professor Jolanda de Vries is chair of the Department Medical BioSciences at Radboud University Medical Center. She was one of the pioneers to translate dendritic cell (DC) biology into potential clinical applications. The first clinical phase I/II studies in which patients were vaccinated with DCs loaded with tumour-specific peptides were initiated in 1997. She also developed a novel immuno-monitoring assay that is highly predictive for extended survival after vaccination with DCs. Her primary scientific interest continues along the line of DC-immunotherapy and in particular the migration and imaging of DC.